IgG antibodies (Abs) specific for central nervous system (CNS) antigens such as myelin oligodendrocytes glycoprotein (MOG) are considered crucial effector molecules in some patients with multiple sclerosis (MS) and related diseases. In the proposed project, we will characterize structural requirements for immune recognition of human MOG and determine IgG-Fc biophysical profiles and effector functions linked to in vivo pathogenicity of human MOG-Abs.
Lünemann, Jan | Department for Neurology |
Lünemann, Jan | Department for Neurology |